Basic Stats
The Factor Analysis chart (below right) shows a view of Verastem, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
Market Cap | |
EV | |
Shares Out. | 61.52 MM |
Earnings Date | |
EPS (TTM) | -2.71 |
Dividend Yield | |
Ex-Dividend Date | |
Borrow Rate | |
Short Shares Avail. | |
Short Interest | |
Short Float | |
Days to Cover | |
Risk Free Rate | 4.17 % |
Price Change (1 yr) | |
Volatility (1 yr) | |
Beta | |
Sharpe Ratio (1 yr) | |
Sortino Ratio (1 yr) |
PE Ratio | |
Price/Book | |
Price/TBV | |
Book/Market | |
EBIT/EV | |
EBIT(3yr avg)/EV | |
ROA | -1.58 |
ROE | -4.16 |
ROIC | -1.38 |
CROIC | 0.67 |
OCROIC | -0.99 |
Implied Volatility | |
Put/Call OI Ratio |
Growth | 49.49 /100 |
Profitability | 34.63 /100 |
Quality Score | 18.20 /100 |
Value Score | |
Momentum Score | |
Stability (Low Vol) Score | |
Analyst Sentiment | |
Fund Sentiment | 35.65 /100 |
Insider Sentiment | |
Officer Sentiment | |
Dividend Score | |
QVM Score | |
Piotroski F-SCORE | 2.00 /9 |
Price Target
The average one-year price target for Verastem, Inc. is US$14.43. The forecasts range from a low of US$12.28 to a high of US$19.64. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Verastem, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
Date | Analyst | Prior | Latest Recommendation |
Action |
---|---|---|---|---|
2024-07-08 | Truist Securities | Buy | Buy | Maintains |
2024-05-29 | Alliance Global Partners | Buy | Buy | Maintains |
2024-05-28 | RBC Capital | Outperform | Outperform | Maintains |
2024-05-28 | HC Wainwright & Co. | Buy | Buy | Reiterate |
2024-05-13 | HC Wainwright & Co. | Buy | Buy | Reiterate |
2024-03-19 | HC Wainwright & Co. | Buy | Buy | Reiterate |
2024-03-15 | RBC Capital | Outperform | Outperform | Reiterate |
2023-11-15 | Truist Securities | Buy | Buy | Maintains |
2023-09-29 | B. Riley Securities | Buy | Buy | Reiterate |
2023-09-27 | B. Riley Securities | Buy | Initiate | |
2023-08-29 | Mizuho | Buy | Buy | Reiterate |
2023-08-09 | RBC Capital | Outperform | Outperform | Maintains |
2023-07-11 | Truist Securities | Buy | Buy | Maintains |
2023-07-06 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
2023-07-03 | RBC Capital | Outperform | Outperform | Maintains |
2023-06-27 | Truist Securities | Buy | Buy | Reiterate |
2023-06-23 | Truist Securities | Buy | Buy | Reiterate |
2023-06-15 | Mizuho | Neutral | Buy | Upgrade |
2023-05-10 | HC Wainwright & Co. | Buy | Maintains | |
2023-03-30 | Mizuho | Neutral | Initiate | |
2023-03-15 | RBC Capital | Outperform | Reiterate | |
2023-03-15 | HC Wainwright & Co. | Buy | Reiterate | |
2022-11-07 | HC Wainwright & Co. | Buy | Maintains | |
2022-10-05 | BTIG | Buy | Maintains | |
2022-04-14 | RBC Capital | Outperform | Initiate | |
2022-03-09 | Truist Securities | Buy | Initiate | |
2021-07-20 | HC Wainwright & Co. | Buy | Maintains | |
2021-07-01 | Alliance Global Partners | Buy | Initiate | |
2021-05-24 | BTIG | Neutral | Buy | Upgrade |
2021-05-13 | HC Wainwright & Co. | Buy | Maintains | |
2020-05-11 | H.C. Wainwright | Buy | Reiterate | |
2020-03-16 | H.C. Wainwright | Buy | Maintains | |
2020-03-03 | Cantor Fitzgerald | Overweight | Maintains | |
2019-05-10 | Raymond James | Outperform | Market Perform | Downgrade |
2019-04-03 | Cantor Fitzgerald | Overweight | Initiate | |
2019-03-14 | Raymond James | Outperform | Outperform | Maintains |
2018-07-13 | BTIG Research | Buy | Initiate | |
2018-05-02 | Seaport Global | Buy | Initiate | |
2017-09-06 | Cantor Fitzgerald | Neutral | Overweight | Upgrade |
2017-04-13 | Oppenheimer | Outperform | Initiate | |
2017-03-24 | H.C. Wainwright | Buy | Reiterate | |
2016-08-09 | Jefferies | Hold | Maintains | |
2015-09-29 | Jefferies | Buy | Hold | Downgrade |
2015-09-29 | Cantor Fitzgerald | Hold | Maintains | |
2015-09-29 | UBS | Buy | Neutral | Downgrade |
2015-09-28 | JMP Securities | Market Outperform | Market Perform | Downgrade |
2015-09-28 | Jefferies | Buy | Hold | Downgrade |
2015-09-28 | Roth Capital | Buy | Neutral | Downgrade |
2015-09-28 | Cantor Fitzgerald | Buy | Hold | Downgrade |
2015-09-28 | Mizuho | Buy | Neutral | Downgrade |
2015-05-12 | UBS | Buy | Maintains | |
2015-04-08 | H.C. Wainwright | Buy | Initiate | |
2015-03-11 | Jefferies | Buy | Maintains | |
2014-07-08 | Oppenheimer | Market Perform | Initiate | |
2014-05-06 | Deutsche Bank | Buy | Initiate | |
2013-07-29 | Jefferies | Buy | Initiate | |
2013-07-08 | Cantor Fitzgerald | Buy | Initiate | |
2013-03-13 | Roth Capital | Buy | Initiate | |
2013-02-22 | Guggenheim | Buy | Initiate | |
2013-02-08 | JMP Securities | Market Outperform | Initiate | |
2024-08-13 | Truist Securities | Buy | Buy | Maintains |
2024-07-24 | B. Riley Securities | Buy | Buy | Maintains |
2024-08-09 | RBC Capital | Outperform | Outperform | Maintains |
2025-04-10 | Jefferies | Buy | Initiate | |
2024-09-30 | Guggenheim | Buy | Initiate | |
2025-01-07 | RBC Capital | Outperform | Outperform | Maintains |
2024-10-18 | RBC Capital | Outperform | Outperform | Reiterate |
2024-10-18 | Cantor Fitzgerald | Overweight | Reiterate | |
2024-10-18 | HC Wainwright & Co. | Buy | Buy | Reiterate |
2024-12-19 | Mizuho | Outperform | Outperform | Maintains |
2024-12-19 | HC Wainwright & Co. | Buy | Buy | Reiterate |
2025-03-21 | RBC Capital | Outperform | Outperform | Maintains |
2025-03-24 | Guggenheim | Buy | Buy | Maintains |
2025-03-24 | HC Wainwright & Co. | Buy | Buy | Maintains |
2025-01-24 | Guggenheim | Buy | Buy | Reiterate |
2024-08-12 | HC Wainwright & Co. | Buy | Buy | Maintains |
2025-01-31 | B. Riley Securities | Buy | Buy | Maintains |
2025-05-09 | HC Wainwright & Co. | Buy | Buy | Maintains |
2025-04-09 | Mizuho | Outperform | Outperform | Maintains |
2025-08-08 | RBC Capital | Outperform | Outperform | Maintains |
2025-06-25 | RBC Capital | Outperform | Outperform | Maintains |